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Abstract
Background: Although vaccination has been proved to be a safe, efficacious, and cost-effective
intervention, immunisation rates remain suboptimal in many European countries, resulting in poor
control of many vaccine-preventable diseases.
Discussion: The Summit of Independent European Vaccination Experts focused on the perception
of vaccines and vaccination by the general public and healthcare professionals and discussed ways
to improve vaccine uptake in Europe.
Despite the substantial impact and importance of the media, healthcare professionals were
identified as the main advocates for vaccination and the most important source of information
about vaccines for the general public. Healthcare professionals should receive more support for
their own education on vaccinology, have rapid access to up-to-date information on vaccines, and
have easy access to consultation with experts regarding vaccination-related problems. Vaccine
information systems should be set up to facilitate promotion of vaccination.
Summary: Every opportunity to administer vaccines should be used, and active reminder systems
should be set up. A European vaccine awareness week should be established.
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Background
Compared with other healthcare interventions, vaccina-
tion has proved to be one of the most cost-effective health
measures of the 20th century, and it is credited with a sub-
stantial role in the overall increase in life expectancy.
However, despite the proven safety and efficacy of vac-
cines, immunisation rates remain suboptimal in many
European countries, and some common vaccine-prevent-
able diseases are not controlled to the extent to which they
could. For example, in 1997, the World Health Organiza-
tion set the objective of eliminating measles from Europe
by 2007. To reach this goal, at least 95% of the population
should receive two doses of the measles vaccine. Recent
data demonstrate that this is not the case. Measles vaccine
coverage remains too low to eliminate the disease, and the
virus is still circulating in many western European coun-
tries. In 2006, Germany was hit by a large measles epi-
demic [1], and measles outbreaks, sometimes numbering
tens of thousands of cases with substantial numbers of
complications and deaths, have also been reported in
recent years from other countries such as Switzerland,
Spain, the Netherlands, France, and Italy (Schumacher RF,
personal communication) [2-7].
Several factors, including inconsistent vaccination sys-
tems, lack of political will, and poor understanding or
false perceptions of vaccination by the public and health-
care professionals (HCPs) have been identified as barriers
to vaccination in Europe [8]. The role of European vacci-
nation policies and systems was discussed by the Summit
of Independent European Vaccination Experts (SIEVE) in
2003 [8] (Table 1). In a recent meeting, the group specifi-
cally addressed the perception of vaccines and vaccination
among the general public and HCPs and discussed how to
improve vaccine uptake in Europe. This article summa-
rizes our key findings and gives suggestions for increasing
vaccination coverage.
Discussion
Public perception of vaccines and vaccination
In developed countries, the general public usually has a
positive view of vaccines and considers vaccination
important. This has been shown in several surveys carried
out in Canada [9,10], the USA [11-13], Belgium [14], Ger-
many [15-17], and Italy [18]. In one telephone survey in
the USA in 1999, 87% of parents deemed immunisation
an extremely important action to keep their children well
[11]. A recent survey supported by the European Vaccine
Manufacturers (EVM) in five European countries (France,
Germany, Italy, the UK, and Spain) revealed a similar atti-
tude: 87% of the 5000 respondents from the general pub-
lic perceived vaccinations as important, and 82% declared
a positive opinion on vaccines [19,20].
A closer look at the results demonstrates, however, that
the situation is not as clear-cut as the figures might sug-
gest. A detailed analysis of the EVM survey showed that
only 37% of the respondents had a "very positive" percep-
tion of the value of vaccinations, whereas 45% of them
were more reserved and indicated only a "somewhat pos-
itive" perception. A recent study in the US [12] showed
that a substantial minority of respondents (15%) consid-
ered vaccines unnecessary to prevent certain infectious
diseases. According to a Canadian survey [9], 58.7% of
respondents agreed that vaccination was among the most
cost-effective medical interventions.
Why is the public perception of vaccines so variable? Con-
cerns and misconceptions about vaccines are common
and have a negative influence on attitudes towards vacci-
nation. In several studies, fear of side-effects has been
expressed as the most frequent reason for not vaccinating
children and adults [17,21]. Other reasons include con-
cerns about the safety of the vaccine ingredients, the ade-
quacy of safety testing, and potential severe long-term
consequences to children [19-27]. Parents have also
expressed concerns about increased adverse events with
combination vaccines [19,20,27,28]. Some parents also
believe that their children receive too many shots, and
that this could weaken the children's immune system, or
that the children could cope with disease without immu-
nisation [11,12,24]. These concerns are rarely based on
scientific evidence.
A lack of knowledge about vaccines among the general
public, especially regarding safety issues, has been con-
Table 1: Society of Independent European Vaccination Experts (SIEVE)
The "Stiftung Präventive Pädiatrie" at the Johannes-Gutenberg-University in Mainz, Germany, has set up a board of independent European 
vaccination experts who meet at regular "Summits of Independent European Vaccination Experts" to evaluate vaccine needs, current research, and 
vaccination policies.
To date, SIEVE members have met to discuss vaccination systems in Europe; the epidemiology of measles; the pneumococcal conjugate vaccine; 
varicella vaccination for all children; and influenza vaccination of children. In addition, the SIEVE steering committee meets at least quarterly to 
discuss vaccination-related issues and to prepare the group discussions. The articles from each meeting represent the consensus view of the 
meeting participants.
The current SIEVE steering committee consists of Heikki Peltola (Helsinki; President), Robert Booy (Westmead; Assessor), and Joe Schmitt (Mainz; 
General Secretary).BMC Medicine 2007, 5:11 http://www.biomedcentral.com/1741-7015/5/11
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firmed by recent studies. In a Canadian study, one-third of
respondents thought that they did not know enough to
comment [9]. In a study in Ireland, parents declared that
they felt poorly informed about vaccination-related issues
[27]. A representative survey carried out in Germany indi-
cated that 50% of parents felt that they were insufficiently
informed about vaccination [16].
It is paradoxical that one of the main barriers to vaccina-
tion is the huge success of many vaccination programmes.
After the near disappearance of the target diseases from
everyday life, the diseases and their complications no
longer serve as a healthy reminder of the continuing need
for prevention through vaccination. Many individuals,
HCPs included, have never witnessed the debilitating dis-
eases that the vaccines prevent. This has resulted in
increased negligence about vaccination, and the balance
has shifted from emphasizing the true benefits of vaccina-
tion to increased suspicion of adverse effects of vaccina-
tion. Parents who are reluctant to have their children or
themselves vaccinated often consider vaccine- preventable
diseases as either rare or mild, or irrelevant to their own
children [23,25,29,30]. Respondents to the EVM survey
were more likely to get vaccinated for travel to a foreign
country than for any other reason [19,20]. Infectious dis-
eases were seen as a problem in other regions, but the
respondents felt safe within the borders of Europe.
Role of the media as a source of information
The media plays an important role as a source of informa-
tion for the general public. However, the quality of the
information provided by the media is variable and can
sometimes be sensational. Many individuals have strong
opinions on vaccinations despite being ill-informed
about vaccine-related issues [31]. There is also a small but
vociferous anti-vaccination lobby (estimated at 3–5% of
the population in Germany [32]) who have quickly
adapted to the internet to disseminate their message [33].
The media can have a positive or a negative effect on the
public perception of vaccination. Unfortunately, recent
vaccination scares have sometimes been mixed by the
media with unrelated health scares such as bovine spong-
iform encephalopathy or blood contaminated with
human immunodeficiency virus, which have undermined
public faith in government healthcare policies [34]. How-
ever, the media could also play a positive role in promot-
ing vaccination and informing the public. An article in the
Sunday Times that revealed a conflict of interest of the
author of a report linking the measles, mumps and rubella
(MMR) vaccination to autism did much to reduce the
credibility of the author's conclusions in the eyes of the
public. However, in many respects, the media were
responsible for giving the false alarm about this report in
the first place [35].
It must be emphasized that a long-term confidential rela-
tionship between medical experts and journalists is of cru-
cial importance. Their relationship is an essential
foundation for educating the public in health-related mat-
ters.
Positive communication with the public
Common misconceptions could be overcome by deliver-
ing accurate, reliable, and positive information on the
benefits of vaccines and the minimal risks associated with
their use, as well as increasing awareness of the diseases
that the vaccines prevent [36]. Such promotion of infor-
mation is a vital part of achieving and maintaining high
levels of uptake of vaccines.
We identified some key factors in communicating with
the general public. First, the public deserves credible and
trustworthy information; that is, clear, reliable, and up-to-
date data on vaccine-preventable diseases and vaccine
safety and efficacy from sources they trust. Second, it is
important to communicate positively, not in a "defen-
sive" way or by raising fears about vaccine-preventable
diseases. Vaccination should be seen as an initiative for
promoting good health, and getting vaccinated could be
seen as establishing "peace of mind". For parents, vaccina-
tion of children could be viewed as complying with a high
standard of childcare and as part of "good parenting prac-
tices". Of course, the information should be adapted to
the different subsets of the population [37]. Decisions
must be made about which groups should be targeted
(e.g. parents, adolescents, elderly, or other at-risk groups),
and education campaigns must be designed to focus on
these specific groups.
Although demographic considerations are important in
identifying target groups, individual perspectives and atti-
tudes must also be considered for such an emotive subject
as vaccination. For example, four distinct groups of par-
ents have been described on basis of the subjects' attitudes
towards vaccination: "vaccine believer", "cautious",
"relaxed", and "unconvinced" [38]. Messages customised
to these groups could improve the understanding and
acceptance of the information on vaccination.
Although education of the general public has been shown
to be successful, the most effective methods to be used
have not been well elucidated [37]. A combination of var-
ious approaches at the European, national, and regional
levels is probably necessary, but education will not be
fully effective unless there is sufficient enthusiasm and
commitment to it at the local level by HCPs and health-
care organisations.BMC Medicine 2007, 5:11 http://www.biomedcentral.com/1741-7015/5/11
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Role of healthcare professionals
HCPs have a key position in vaccine uptake. They serve as
an important source of information for the general public
and are the main drivers of vaccination programmes. In
the EVM survey [19,20], 68% of respondents cited HCPs
as their main information source on vaccines in general,
and 81% of parents considered HCPs to be a primary
source of information regarding vaccination of their chil-
dren. In a survey on vaccination in Spain, 69% of
respondents cited the paediatrician as their most impor-
tant source of information [28].
With respect to vaccination, the opinions of HCPs are
often more important than the parents' or patients' own
points of view. Many parents of fully immunised children
express similar attitudes and beliefs to parents of under-
immunised children. The determining factor in vaccine
acceptance is the HCP's attitude [24]. Physicians' views on
vaccine safety are critical in determining whether vaccines
will or will not be accepted [39]. The strong link between
HCPs' perceptions of vaccination and vaccine uptake has
been documented by studies from several countries,
including France [19,20], the UK [19,20], Belgium [40],
Germany [15,19,20], Italy [18-20], and the USA
[11,22,41].
A role in vaccine acceptance is not limited to family phy-
sicians and paediatricians. Nurses, pharmacists [42], mid-
wives, and professionals working in various types of
childcare centres may also have an important role in edu-
cating and informing the general public.
Information and education of healthcare professionals
HCPs have generally positive attitudes towards vaccina-
tion. In the EVM study, 84% of the 800 healthcare profes-
sionals interviewed affirmed very positive perceptions of
vaccines and the value of vaccination, and another 14%
had somewhat positive perceptions [19,20]. However,
their level of information on vaccination issues was not
always optimum. Surprisingly, education on vaccines and
vaccination is poor or nonexistent in the medical curricula
in most western European countries. The recent renewal
process of the medical curricula at many European univer-
sities provides an opportunity to incorporate more exten-
sive training on vaccinology for future generations of
physicians. Similar efforts should be made for pharmacy
and nursing curricula. A survey to assess the current state
of vaccine-related teaching in the formal education of
HCPs is recommended as a first step in improving the sys-
tem.
HCPs often lack precise information on specific issues. In
an American study [43], over 90% of 268 physicians inter-
viewed thought that vaccine efficacy was high and that the
likelihood of serious side effects was low. However, only
37% could give an accurate estimate of the likelihood that
an infant with pertussis would need hospitalisation. Many
respondents had inaccurate views of vaccine contraindica-
tions. For example, 37% would not administer the MMR
vaccine to a child whose mother was pregnant even
though administration of a live, attenuated virus vaccine
to household members does not present a known hazard
to pregnant women [44]. Likewise, 21% would not
administer four vaccines simultaneously, despite the fact
that such co-administration has been shown to be per-
fectly safe and effective and is an essential component of
childhood vaccination programmes [44].
Most HCPs participating in the EVM study [19,20] were
practicing vaccinators, and therefore it is not surprising
that they were satisfied with their level of information
(satisfaction level of 8.3 on a scale from 1 to 10). Scientific
journals were cited as their main source of information. It
is remarkable, however, that even among well-informed
physicians, there was a need for more information, espe-
cially about new vaccines. A study carried out in Ireland
revealed that the levels of knowledge about vaccines and
vaccine-preventable diseases varied greatly both within
and between different groups of HCPs [27]. To varying
degrees, HCPs felt that they were ill-equipped to properly
inform parents about vaccine-related issues, with those
who were less involved in vaccination expressing more
concern. They complained about a lack of user-friendly
information or the absence of critical information when it
was needed most (such as during vaccine scares, when the
HCPs are the first-line responders). HCPs all expressed a
need for timely and accurate information to help them
address parental concerns regarding vaccination [27].
HCPs need rapid access to relevant, up-to-date, and objec-
tive information, instead of having to rely on press
releases, leaflets from pharmaceutical companies, or the
media. One successful initiative in this context is INFO-
VAC http://www.infovac.ch. Created in Switzerland in
2000 and established in France in 2003, INFOVAC is an
interactive consultation/information system on vaccines
and vaccination for general practitioners and paediatri-
cians. It is run by a network of academic paediatric experts
in infectious diseases, who can be contacted at a central e-
mail address. HCPs can address every question concern-
ing vaccination and be assured of an answer from an
expert within 24–48 hours.
INFOVAC also distributes monthly bulletins on the latest
developments in vaccinology [39]. One of the strong
points of INFOVAC is that because of its broad academic
network it can respond to a wide range of questions from
the vaccinators. This successful experience could serve as a
model for other countries.BMC Medicine 2007, 5:11 http://www.biomedcentral.com/1741-7015/5/11
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Another successful initiative, started in 2001 by the Uni-
versity of Antwerp, Belgium, is an annual vaccination
"Q&A" day. The day is organised without any support
from industry in order to avoid any real or perceived bias
or conflict of interest. The participating HCPs (on average
350–500 physicians and nurses) set up the programme by
sending in their questions in advance, and a panel of local
experts is invited to respond. The goal of these annual
meetings is to provide up-to-date information for the par-
ticipants [45].
HCPs not only need information regarding particular vac-
cines but they also need to be informed about the epide-
miology and effect of infectious diseases and about the
vaccination rates in their country or region to be able to
design appropriate strategies.
Healthcare professionals need more time to inform the 
public
In many countries, HCPs act as the principal source of
information on vaccines and vaccination for their
patients, and thus they are essential for the population at
large. Several studies have shown that this places a heavy
time burden on the already tight schedules of HCPs. Lack
of time is an important cause of missed vaccination
opportunities [46]. In one survey, paediatricians, family
physicians, and nurses in private practice reported initiat-
ing discussion in 70% of visits on the immunisation
schedule, common side effects, and when to call the
clinic. These HCPs considered lack of time as the greatest
barrier to vaccine risk-benefit communication [47]. More
time was needed to alleviate parental concerns generated
by scare stories [27]. The need to devote attention to treat-
ing active medical problems was cited as the most com-
mon reason for missed pneumococcal vaccinations in a
study of American physicians [48].
Any extra time spent by HCPs addressing vaccine issues is
not time wasted. Practices that allowed more time for
acute care visits and used more immunisation promotion
activities were found to have higher influenza and pneu-
mococcal vaccination rates among adults >65 years of age
[46].
Centralised computer systems and active reminders
Many people do not get fully vaccinated, not because they
are against vaccination, but because they tend to forget
about it and/or because vaccination schedules are too
complex to remember. Active reminder systems such as
postcards, telephone calls, or other forms of communica-
tion should be set up. Reminders to both patients and
providers have been shown to increase vaccination uptake
[11,24], but unfortunately these interventions are under-
used in primary care and even illegal in some countries
such as Germany.
Centralised computer systems that would rapidly inform
the HCPs about the vaccination status of their patients
could substantially promote vaccination. Besides provid-
ing important information about the patients to the
HCPs, centralised computer systems could be used to pro-
vide timely information on local vaccine coverage levels.
Availability of reliable data on vaccine coverage is essen-
tial for the evaluation of the effectiveness of any interven-
tion strategy [49]. Computers could also be used to help
in monitoring the occurrence of vaccine-related adverse
events and collecting data on patient response behaviour.
Computerized systems are already in place in some
regions of Europe. For example, in the autonomous
region of Murcia Province, Spain, 99% of newborn babies
are entered into the Registry of the Computerised Vaccina-
tion Programme of the Directorate General of Public
Health. All parents receive a letter of introduction, a vacci-
nation booklet, and a card with a barcode for each vaccine
that the child should receive during the first 2 years. Vac-
cines administered are recorded on the card, which is con-
nected to the registry managed by the data management
centre. This registry provides: (i) a list of properly vacci-
nated persons; (ii) a list of insufficiently vaccinated per-
sons who are periodically reminded by mail or telephone
of the convenience of keeping up with the schedule; and
(iii) a certificate of vaccination status [28].
In Flanders, Belgium, a pilot electronic vaccination data-
base, Vaccinnet, was set up in 2003 for infants visiting
"well baby" clinics [50]. By 2006-7, this database will
cover all infants, and it will later expand to cover all child-
hood and adolescent vaccines administered by general
practitioners, paediatricians, and school physicians, plus
adult vaccines given by general practitioners and occupa-
tional health physicians. Vaccinnet aims to avoid the over-
use of vaccines, identify pockets of vaccine underuse,
record vaccine coverage, and evaluate the success of vacci-
nation programmes. Vaccinnet is a central ordering sys-
tem for vaccines and can be used as a  system to the record
coverage and to report adverse events.
Increased opportunities for vaccination
Every opportunity to administer vaccines should be used.
For example, patients discharged from hospital for pul-
monary disease should be offered immediate injection of
pneumococcal vaccine and, in the autumn, of influenza
vaccine. MMR vaccine should be offered to seronegative
women when they are discharged from the maternity
ward. Easy access to vaccination in non-traditional set-
tings should also be considered. Depending on national
and local circumstances, vaccinations could be performed
in settings such as childcare centres and nursing homes
and during home visits. In addition, where available,
access to vaccination centres should be facilitated, withBMC Medicine 2007, 5:11 http://www.biomedcentral.com/1741-7015/5/11
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evening and weekend opening hours. Increasing opportu-
nities for vaccination will increase vaccine uptake.
Standing orders that authorise nurses and pharmacists to
administer vaccines without a physician contact according
to an institution-approved or physician-approved proto-
col have proved successful in increasing vaccination rates
in adults [51]. They were found to be more effective than
computerised reminders for increasing both influenza
and pneumococcal vaccine administration [52]. They can
be implemented in inpatient and outpatient facilities and
other non-traditional environments, greatly increasing
the opportunities for vaccination.
Summary
Conclusion
Vaccination rates in Europe are not what they should or
could be. Public perception of vaccination is important,
but rather than concentrating on failures of vaccination it
might be better to identify and implement strategies that
focus on HCPs and that have been shown to work.
Clearly, HCPs play a central role in vaccine uptake. They
remain the most important sources of information to the
public and the most important advocates of vaccination
although their contributions are often unappreciated and
underused. To feel confident in carrying out their respon-
sibilities, they need the support of health authorities and
they also need to be sufficiently informed about vaccine-
related issues and problems. The INFOVAC network is a
good step in this direction, and it could be expanded to
other countries. In addition, medical education should be
revised to include additional training in vaccinology in
the medical, pharmaceutical, and nursing curricula. The
general public could also benefit from better education.
Many of the fears and concerns of lay persons could be
overcome by easy access to accurate information pre-
sented in an understandable format.
Even if all the information would be available, however,
the lack of time for communication remains a great bar-
rier to vaccination and must be addressed. Moreover, once
the idea of vaccination is accepted, the opportunities for
administering the injections themselves need to be
increased.
Many of the issues highlighted here could be addressed
during a European Vaccination Awareness Week. Such an
event could involve the media to inform the general pub-
lic, to raise awareness, and to promote dialogue between
HCPs and the public. Such events have been successfully
implemented in the USA ("National Immunization
Awareness Month [53]) and Canada (National Immuni-
zation Awareness Week [54]. The Pan American Health
Organisation has organised an international event (Vacci-
nation Week in the Americas [55]). Such initiatives focus
the attention of the public on the importance of vaccina-
tions. National and Europe-wide organisations could pro-
mote and support community-based actions to inform
people at the local level. These would encourage people to
check their vaccination status, educate themselves on vac-
cination issues, and perhaps even get vaccinated.
Competing interests
SIEVE is supported by an unrestricted educational grant
from the Stiftung Präventive Pädiatrie at the Johannes-
Gutenberg-University, Mainz, Germany. There was no
other funding source.
Authors' contributions
All authors contributed to the manuscript by a country-
specific presentation and by discussing the topic at a 2-day
meeting held in Frankfurt, November 12–14 (2004). Fol-
lowing the meeting, the manuscript was prepared by a sci-
ence writer (Dr Britta Gröndahl) employed by the
University of Mainz at the department of the first author.
The first author was in charge of producing the final ver-
sion of the manuscript with input via "electronic discus-
sions".
Acknowledgements
This report is based on the evaluation of data and discussions at and follow-
ing the Summit of Independent European Vaccination Experts (SIEVE) in 
Frankfurt, Germany, November 2004. The authors greatly appreciate the 
help of Betty Dodet and Simon M. Jones in the preparation of this manu-
script, and Dr Britta Gröndahl for help with organizing the meeting.
Table 2: Suggestions from SIEVE
• Implement an integrated advocacy and communication programme to inform the public.
• Promote the training of HCPs not only in the scientific and medical aspects of vaccination but also in the management of vaccination programmes.
• Conduct a survey of vaccinology education in the curricula of HCPs in European countries and make recommendations based on the results.
• Extend and support an INFOVAC-like network in Europe.
• Provide support to HCPs for increasing immunisation rates in their patients:
 By allocating them sufficient time during their patients' consultation to inform them about vaccination.
 By setting up computerized information systems for HCPs and providing them with training that will allow them to record their patients' 
vaccination status and implement active reminder programmes.
•Increase vaccination opportunities (e.g., standing orders, more convenient opening hours).
• Support the organisation of a "European Immunisation Awareness Week". HCP, healthcare professional.BMC Medicine 2007, 5:11 http://www.biomedcentral.com/1741-7015/5/11
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